Epithelial Cell Culture Media Market Growing at a CAGR of 11.4% and it is expected to reach US$ 303,040.33 thousand by 2028, Says The Insight Partners
According to our new research study on “Epithelial Cell Culture Media Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type and End User,” the market is expected to reach US$ 303,040.33 thousand by 2028 from US$ 128,155.95 thousand in 2020; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The growth of the epithelial cell culture media market is mainly attributed to the factors such as the increasing applications of epithelial cells and surge in funding for epithelial cell research. However, the risk of contamination, misidentification, and random alternations in cell lines hinders the market growth.
Epithelial cells are widespread throughout the body. These cells cover body surfaces, line body cavities, hollow organs, and major tissues in glands. These cells perform functions such as protection, absorption, secretion, excretion, diffusion, filtration, and sensory reception. These cells are widely used in disease modeling, toxicity studies, and drug discovery, among other applications. The growth of the epithelial cell culture media market is attributed to the factors such as the increasing applications of epithelial cells and surge in funding for epithelial cell research. However, the risk of contamination, misidentification, and random alternations in cell lines hinders the market growth.
Request for sample Pages on Epithelial Cell Culture Media Market Study at: https://www.theinsightpartners.com/sample/TIPRE00022539/
Epithelial Cell Culture Media Market: Competition Landscape and Key Developments
PromoCell GmbH; Merck KGaA; ATCC; AXOL Bioscience Ltd.; Thermo Fisher Scientific, Inc.; Bio-Techne Corporation; Celprogen, Inc.; Lonza Group AG; HiMedia Laboratories; and Cell Biologics, Inc are among the leading companies operating in the epithelial cell culture media market.
Surge in Funding for Epithelial Cell Research
Extensive funding for supporting the research projects involving the use of epithelial cells to identify new therapeutic solutions for chronic diseases is propelling the demand for epithelial cell culture media. For instance, the National Institutes of Health (NIH), US, funded a 3-year research project (2013–2016) that was conducted at the University of Kentucky. The institute granted US$ 307,395 in funds in 2014 to examine processes controlling inflammation in colitis, a condition that stimulates epithelial stem cell growth and differentiation and increases the risk of colon cancer.
In 2018, scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research along with those at the Stein Eye Institute were granted US$ 5.1 million by the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions. The project setup includes the use of patients’ own skin cells to generate autologous induced pluripotent stem cells to derive retinal pigment epithelium cells that are lost in blinding eye conditions.
Epithelial Cell Culture Media Market: Segmental Overview
Based on product type, the epithelial cell culture media market is segmented into human mammary epithelial cell, bronchia/trachea epithelial cell, renal epithelial cells, and others. In 2020, bronchia/trachea epithelial cell segment accounted for the largest share of the market. Bronchial epithelium plays a vital role in airway defense by protecting the respiratory tract from several infections. Thus, the bronchial epithelial cell line is extensively used to model barrier function of the airway epithelium and to study respiratory ion transport and the function of cystic fibrosis transmembrane conductance regulator (CFTR). It is also used in lipidomic analysis for comparison with cystic fibrosis cell line. Factors contribution to the growth of the segment are increasing prevalence of respiratory diseases and growing research and development activities to treat respiratory diseases.
Based on end user, the epithelial cell culture media treatment market is segmented into biopharmaceutical companies, academic and research laboratories, and others. The biopharmaceutical companies segment held the largest share of the market in 2020, whereas the academic and research laboratories segment is anticipated to register the highest CAGR of in the market during the forecast period.
Epithelial Cell Culture Media Market – by Geography
- North America
- Rest of Europe
- Asia Pacific (APAC)
- South Korea
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Rest of South and Central America
Buy Copy of Epithelial Cell Culture Media Market Research Study at: https://www.theinsightpartners.com/buy/TIPRE00022539/
Browse Related Report
Cell Culture Media Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Lysogeny Broth, Serum-Free Media, Specialty Media, Classical Media, Stem Cell Media, Chemically Defined Media, Others); Application (Biopharmaceuticals, Biological Drug Discovery, Cancer Research, Tissue Engineering, Stem Cell Technologies, Other Applications); End User (Academic Institute, Research and Development Laboratory, Biotechnology Industry, Other End Users) and Geography
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us: